Related references
Note: Only part of the references are listed.Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
Fatma Berri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells
Eimear M. Gleeson et al.
HAEMATOLOGICA (2014)
Coagulation, Protease-Activated Receptors, and Viral Myocarditis
Silvio Antoniak et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2014)
A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection
Marlene Brandes et al.
CELL (2013)
PAR1 contributes to influenza A virus pathogenicity in mice
Khaled Khoufache et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
PAR-1 contributes to the innate immune response during viral infection
Silvio Antoniak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase
Yaling Xing et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Enhanced Effector Function of CD8+ T Cells From Healthy Controls and HIV-Infected Patients Occurs Through Thrombin Activation of Protease-Activated Receptor 1
Amanda Hurley et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3-Induced Myocarditis
Alice Weithauser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
Zhili Xu et al.
NATURE MEDICINE (2013)
Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
Laetitia Aerts et al.
PLOS ONE (2013)
Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis
Fatma Berri et al.
PLOS PATHOGENS (2013)
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
Jason V. Baker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The Economic Burden of Dengue
Duane J. Gubler
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response
Claudius Seitz et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection
Michael R. Sutherland et al.
BLOOD (2012)
β-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells
Fabrice Jaffre et al.
CIRCULATION (2012)
Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages
Quan M. Nhu et al.
INNATE IMMUNITY (2012)
Review: Viral infections and mechanisms of thrombosis and bleeding
M. Goeijenbier et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus
Konstantin Doronin et al.
SCIENCE (2012)
Inhibitory Influence of the Hexapeptidic Sequence SLIGRL on Influenza A Virus Infection in Mice
Richard J. Betts et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Impact of Endogenous Protein C on Pulmonary Coagulation and Injury during Lethal H1N1 Influenza in Mice
Marcel Schouten et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS
Shaona Acharjee et al.
BRAIN (2011)
Molecular mimicry between virus and host and its implications for dengue disease pathogenesis
Yee-Shin Lin et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Protease-activated Receptors and Myocardial Infarction
Silvio Antoniak et al.
IUBMB LIFE (2011)
TRIF Is a Critical Survival Factor in Viral Cardiomyopathy
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2011)
Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes
Hai-Yan Pan et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
Nicholas T. Funderburg et al.
BLOOD (2010)
Signal transduction by protease-activated receptors
Unice J. K. Soh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza
M. Schouten et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages
Yu Zhou et al.
IMMUNOLOGY (2010)
A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy
Carlos Gorbea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis
Sally Eyers et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2010)
Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus
Xiangjie Sun et al.
JOURNAL OF VIROLOGY (2010)
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
Q. M. Nhu et al.
MUCOSAL IMMUNOLOGY (2010)
Myocarditis
Lori A. Blauwet et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
Lynda Coughlan et al.
VIRUSES-BASEL (2010)
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study
Marcel Schouten et al.
CRITICAL CARE (2010)
Interferons and viral infections
Volker Fensterl et al.
BIOFACTORS (2009)
A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells
Aya Shibamiya et al.
BLOOD (2009)
Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity
Sheng Zheng et al.
CANCER SCIENCE (2009)
CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis
Ji Yuan et al.
CIRCULATION RESEARCH (2009)
Salicylates and Pandemic Influenza Mortality, 1918-1919 Pharmacology, Pathology, and Historic Evidence
Karen M. Starko
CLINICAL INFECTIOUS DISEASES (2009)
Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing
Tsukasa Seya et al.
IMMUNOLOGICAL REVIEWS (2009)
Protease-activated receptor-1 regulates cytokine production and induces the suppressor of cytokine signaling-3 in microglia
Cinzia Fabrizi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
Protective Role for Protease-Activated Receptor-2 against Influenza Virus Pathogenesis via an IFN-γ-Dependent Pathway
Khaled Khoufache et al.
JOURNAL OF IMMUNOLOGY (2009)
Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection
Martin J. Richer et al.
PLOS ONE (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Mast cells play a critical role in the pathogenesis of viral myocarditis
Hirokazu Higuchi et al.
CIRCULATION (2008)
Analysis of proteinase-activated receptor 2 and TLR4 signal transduction - A novel paradigm for receptor cooperativity
Prasad Rallabhandi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Agonists of proteinase-activated receptor-2 enhance IFN-γ-inducible effects on human monocytes:: Role in influenza a infection
Micha Feld et al.
JOURNAL OF IMMUNOLOGY (2008)
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity
V. Shpacovitch et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Viral myocarditis and coagulopathy:: Increased tissue factor expression and plasma thrombogenicity
Silvio Antoniak et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
The contribution of PARs to inflammation and immunity to fungi
S. Moretti et al.
MUCOSAL IMMUNOLOGY (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Protease-activated receptors: novel PARtners in innate immunity
V. Shpacovitch et al.
TRENDS IN IMMUNOLOGY (2007)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral Keratinocytes
Rodrigo A. Giacaman et al.
JOURNAL OF IMMUNOLOGY (2007)
Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1
M. R. Sutherland et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-1-dependent antiviral responses in human lung epithelial cells
Ronan Le Goffic et al.
JOURNAL OF IMMUNOLOGY (2007)
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1
Tymen T. Keller et al.
CIRCULATION RESEARCH (2006)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells - More terminators than activators
M Chignard et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Heparan sulphate proteoglyeans and viral vectors:: Ally or foe?
RR Vivés et al.
CURRENT GENE THERAPY (2006)
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors
J Schuettrumpf et al.
MOLECULAR THERAPY (2006)
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia
Ronan Le Goffic et al.
PLOS PATHOGENS (2006)
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis
DCJ Howell et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Basal and reovirus-induced beta interferon (IFN-β) and IFN-β-stimulated gene expression are cell type specific in the cardiac protective response
MJ Stewart et al.
JOURNAL OF VIROLOGY (2005)
The cardiovascular actions of protease-activated receptors
SF Steinberg
MOLECULAR PHARMACOLOGY (2005)
Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection
D Fairweather et al.
AUTOIMMUNITY (2004)
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
R Pawlinski et al.
BLOOD (2004)
Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice
RS Lan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys
TW Geisbert et al.
LANCET (2003)
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event
TW Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Heparan sulfates and coxsackievirus-adenovirus receptor:: Each one mediates coxsackievirus B3PD infection
AE Zautner et al.
JOURNAL OF VIROLOGY (2003)
Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis
LA Boven et al.
JOURNAL OF IMMUNOLOGY (2003)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Modulation of airway smooth muscle tone by protease activated receptor-1,-2,-3 and-4 in trachea isolated from influenza A virus-infected mice
RS Lan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
